| Message: | 1. PROSCAR; PROSTIDE; N-(2-METHYL-2-PROPYL)-3-OXO-4-AZA-5ALPHA-ANDROST-1-ENE-17BETA-CARBOXAMIDE; MK-906; (5alpha, 17beta)-(1, 1-dimethylethyl)-3-oxo-4-azaandrost-1-ene-17-carboxamide; 17beta-(n-tert-butylcarbamoyl)-4-aza-5alpha-androst-1-en-3-one; 4-azaandrost-1-ene-17-carboxamide, n-(1, 1-dimethylethyl)-3-oxo-, (5-alpha, 17-be; 4-azaandrost-1-ene-17-carboxamide, n-(1, 1-dimethylethyl)-3-oxo-, (5alpha, 17beta
CAS No.: 98319-26-7
Assay: 99%
Molecular Formula: C23H36N2O2
Molecular Weight: 372.54
Packing: Foil bag
Appearance: White or white crystalline solid. Soluble in chloroform, dimethyl sulfoxide, ethanol, methanol or propanol, insoluble in propylene glycol or polyethylene glycol 400
Usage: The drug can be very effective in reducing blood and dihydro testosterone within the prostate. Finasteride no affinity to the androgen receptor
Finasteride (brand names Proscar and Propecia by Merck, among other generic names) is a synthetic drug for the treatment of benign prostatic hyperplasia (BPH) and male pattern baldness (MPB). It is a type II 5α -reductase inhibitor. 5α -reductase is an enzyme that converts testosterone to
Dihydrotestosterone (DHT). Physicians use finasteride for the treatment of benign prostatic hyperplasia (BPH), informally known as an enlarged prostate. As measured by hair counts, in a five-year study of men with mild to moderate hair loss, two out of three of the men who took 1 mg of finasteride daily regrew some hair. In contrast, all of the men in the study who were not taking finasteride lost hair. In the same study, based on photographs that were reviewed by an independent panel of dermatologists, 48% of those treated with finasteride experienced visible regrowth of hair, and a further 42% had no further loss. Average hair count in the treatment group remained above baseline, and showed an increasing difference from hair count in the placebo group, for all five years of the study.
|
my account
